Counseling about hepatitis C transmission and alcohol consumption and treatment with medications that are simpler, faster and more effective than ever. All possible in primary care. Take the post-test to claim your credit.
Learn the basics of hepatitis C, including how the virus is transmitted, who to screen for the infection, and why screening is critical to interrupting the epidemic of hepatitis C and its life-threatening consequences. Take the post-test to claim your credit.
Hep C (HCV) treatment is easier and more effective, than ever. Cure is almost always expected when treated—even current drug users—so learn how you can cure HCV and help prevent re-infection, liver damage, cancer and death. Take the post-test to claim your credit.
Hepatitis C is a huge killer, but it doesn’t have to be. Cure is possible, even among drug users. Be part of the cure by learning what is involved in screening (hint: not much) and how screening can save lives. Take the post-test to claim your credit.
Treatments for HIV are highly effective, but only when they are taken by those who need them. Learn about strategies to improve adherence and the importance of collaborative care. Do your part to reduce the morbidity and mortality associated with HIV. Take the post-test to claim your credit.
HIV infection can be stopped in its tracks. Learn the importance of screening for the virus and how to overcome barriers that get in your way. You can help prevent the spread of HIV and the illness that it brings. Take the post-test to claim your credit.
Volume 4, Issue 8.
In this podcast guest author Steven Rowe, MD, Associate Professor of Medicine from the University of Alabama at Birmingham, describes how CFTR modulator therapy fits into the clinical armamentarium of CF lung disease; identifies which patients are most appropriate for CF modulator treatment; and describes current research efforts and how to identify patients suitable for referral for consideration in CFTR modulator clinical trials.
Volume 4, Issue 6.
In this podcast guest author Dr. Margaret Rosenfeld from the University of Washington School of Medicine, discusses the rationale for early Pseudomonas aeruginosa eradication, Identifies the inhaled and oral antibiotics that have been compared in clinical trials for early Pseudomonas eradication, and describes the potential adverse effects of early Pseudomonas eradication therapy.
Volume 4, Issue 4.
In this podcast guest author Amanda Radmer Leonard, Pediatric Nutrition Practitioner, of the Johns Hopkins Children’s Center, describes approaches to the treatment of low vitamin D levels in patients with cystic ﬁbrosis, discuss the variability of fecal elastase result during the ﬁrst year of life, and summarizes the importance of tailoring nutritional interventions to speciﬁc patient and family situations.
Volume 4, Issue 2.
Nonadherence to any medical regimen is common particularly among adolescents and young adults, and cystic fibrosis (CF) is no exception. There are many barriers to following the complex daily regimen that CF management requires, and researchers and clinicians have not yet found the ideal approach for counseling and supporting patients to improve and maintain their level of adherence. In this podcast Dr. Kristin Riekert, of The Johns Hopkins Adherence Research Center discusses best practices for determining which clinic patients are nonadherent and Identifies risk factors for nonadherence.